Inventiva announces exercise of option by Boehringer Ingelheim to jointly develop potential new treatments for idiopathic pulmonary fibrosis (IPF) 5 September 2017
Inventiva and AbbVie Extend Agreement to Discover New Potent Orally-Available Small Molecule RORγ Inverse Agonist Drug Candidates 4 September 2017
Inventiva Announces Receipt of €2.3 million in Grant Funding for YAP/TEAD Protein Research Program 19 September 2016
Boehringer Ingelheim and Inventiva collaborate to develop potential new treatments for idiopathic pulmonary fibrosis 31 May 2016
